Nanobiotix
Healthcare · EUR · EPA
Price
€34.56
Cap
€1.39B
Earnings
—
30d Trend
+22.7%
148% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 26×Macro 0.99 (−1%)=26
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
5-10 day swing — oversold bounce candidate
BRAIN47'S ASSESSMENT
I rate Nanobiotix at 26/100 — a VERY WEAK reading on the Brain47 Signal. The strongest factor is quality at 55/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.
PAST PERFORMANCE
1 MONTH
-43.2%
3 MONTHS
-48.8%
12 MONTHS
-74.9%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
5-10 day swing — oversold bounce candidate. Quality (55) and Technical (35) are the primary strengths. I note that momentum is the weakest area at 8/100 — this warrants monitoring. Historical volatility is elevated at 148%. I classify this as a speculative position — elevated volatility at 148% and smaller market cap define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.